IBRXNasdaq United States
Market cap
$8.097 B
$7.64 +4.37%
Close of 7 Aug 2026
Revenue
$113.3M
#2475 by revenue
Earnings
-$351.5M
Loss-making
Shares outstanding
1,059,836,273
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for ImmunityBio are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.